Suicide is the third leading cause of death in the US among people under the age of 45. Yet psychiatrists know remarkably little about what treatments can most effectively prevent people from killing themselves. For the most part, investigators have shied away from studying the problem head-on because designing intervention studies with suicidal subjects is fraught with difficulty. Elie Dolgin talks to the small group of mental health professionals who are hoping to put an end to that.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Oquendo, M.A., Stanley, B., Ellis, S.P. & Mann, J.J. Am. J. Psychiatry. 161, 1558–1563 (2004).
Oquendo, M.A. et al. Am. J. Psychiatry 168, 1050–1056 (2011).
Perlis, R.H. Am. J. Psychiatry 168, 1009–1011 (2011).
Montgomery, S.A. & Montgomery, D. J. Affect. Disord. 4, 291–298 (1982).
Meltzer, H.Y. et al. Arch. Gen. Psychiatry 60, 82–91 (2003).
Baldessarini, R.J. et al. Bipolar Disord. 8, 625–639 (2006).
Lauterbach, E. et al. Acta Psychiatr. Scand. 118, 469–479 (2008).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Dolgin, E. The Ultimate Endpoint. Nat Med 18, 190–193 (2012). https://doi.org/10.1038/nm0212-190
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm0212-190
This article is cited by
-
Counseling on Access to Lethal Means (CALM): An Evaluation of a Suicide Prevention Means Restriction Training Program for Mental Health Providers
Community Mental Health Journal (2018)
-
A safe lithium mimetic for bipolar disorder
Nature Communications (2013)